Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.
about
The role of NK cells in HIV-1 protection: autologous, allogeneic or both?Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus PeptidesOpen conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1Psoriasis patients are enriched for genetic variants that protect against HIV-1 diseaseSelection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaNatural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patientsHost genetics influences on HIV type-1 disease.KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Copy number variation of KIR genes influences HIV-1 control.The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralizationNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.KIR/HLA interactions and pathogen immunityHuman immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reactionKIR-HLA intercourse in HIV diseaseStructural insights into activation of antiviral NK cell responsesHost genetic determinants of HIV pathogenesis: an immunologic perspectiveConferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral loadComprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.KIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NK cell subsets in SIV-infected Mamu-A*01-negative rhesus macaquesHLA/KIR restraint of HIV: surviving the fittestA method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.HLA and infectious diseases.KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.Role of KIR3DS1 in human diseases.α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort.
P2860
Q26753146-2BDD64E2-AA72-4FCD-9382-0A680771A225Q27317377-AD88B16A-0223-4321-A6CF-FF0A1DBC9C37Q28277389-B734E239-6F59-4282-ACC0-53B61ACA1148Q28483308-3B7A1B21-55D3-435E-AF54-96846CBAEE0AQ28607344-340D09FA-E777-40FC-B1E5-CB01CEA0BD91Q31115968-2739743B-A32F-47EA-875D-769355A642F5Q33775595-69487717-7DFA-471A-9151-F853A2A55788Q33827994-1FD215A9-8BAF-41CF-B503-68FCB6B27E4FQ33828392-762DEED5-A243-4772-A3F9-4597D75427DBQ34090869-DDB8CC68-A963-45D7-9018-5ED1CFC2F701Q34234905-67F0F872-F0A4-499B-9A45-ECEFB64F1FE4Q34741864-59EADC72-3BE4-4A92-ADCA-5A868EDB12CEQ34995326-0EF2057D-2369-4D35-8A6C-8E6085569482Q35001169-30CFC51A-5EA1-4F7A-AA02-40597A849330Q35076703-93495C94-DC18-447F-AAD7-E0F4C173812CQ35148027-E08FF3E9-2579-40E8-911C-9043CBA90FC4Q36296307-5280615C-AE43-465E-BB96-CF6BDDEB568EQ36317668-E082F334-C344-4A02-ADF8-83346A7A9B29Q36329596-DAB7DC07-B74E-4821-8DDE-0C55D74D8177Q36594176-54F3F27D-5CCE-4D92-83E2-AD62A6DC7ABBQ36606569-D6310151-12A9-4310-9662-061F72BB4D1BQ36673356-B230699F-B3CC-46C3-9D06-8DB18489AE16Q36747731-8820E9DD-C0B6-4ACA-B3FD-0654A550B655Q36759934-079FADFE-EC34-4E6D-993E-532ADC82DDCCQ37051248-2699D5BA-2250-4A8F-9191-072122A4190FQ37094767-4B56D176-CDFD-41B4-8B80-81B6D9A2C59DQ37128253-15910689-0CFF-49C9-B94E-DD16756CE775Q37444410-F1566E8E-37D0-4796-A6B0-8206E2720713Q37471733-11FACD25-1415-4B8F-912A-50285785F9B1Q38057745-58F95CC5-230E-47BC-B8F8-2E6ECAD53F6CQ38636110-B9AB7000-43B8-473E-BA40-1108FC2243CBQ40122626-A2C43039-0820-40FC-9594-C44DAE7433A0Q40653419-EC7F8B40-D3A1-4E9E-95F8-276C635226F8Q43127366-9C76E19F-B392-4009-95C5-D50E27009CDCQ46722989-A5744C68-08A4-4DC2-B097-F3FC83FED152Q54091890-16FE1274-07FD-442F-B712-5E45BB9C6E7F
P2860
Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@ast
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@en
type
label
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@ast
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@en
prefLabel
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@ast
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@en
P2093
P2860
P921
P1433
P1476
Synergy or independence? Decip ...... rly HIV-1 disease progression.
@en
P2093
Jason D Barbour
Jay A Levy
Jorge R Oksenberg
Stacy J Caillier
Uma Sriram
P2860
P356
10.1371/JOURNAL.PPAT.0030043
P5008
P577
2007-04-01T00:00:00Z